Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 53 | 3.250 |
Why?
|
Tilt-Table Test | 6 | 2024 | 79 | 2.810 |
Why?
|
Autonomic Nervous System Diseases | 5 | 2022 | 269 | 2.520 |
Why?
|
Orthostatic Intolerance | 4 | 2024 | 23 | 2.410 |
Why?
|
Autonomic Nervous System | 5 | 2022 | 703 | 1.590 |
Why?
|
Multiple System Atrophy | 6 | 2022 | 130 | 1.590 |
Why?
|
Cerebrovascular Circulation | 13 | 2024 | 2727 | 1.580 |
Why?
|
Heart Rate | 9 | 2024 | 4195 | 1.240 |
Why?
|
Mastocytosis | 4 | 2024 | 150 | 1.170 |
Why?
|
Blood Pressure | 12 | 2024 | 8481 | 0.980 |
Why?
|
Subthalamic Nucleus | 5 | 2011 | 195 | 0.950 |
Why?
|
Penicillanic Acid | 1 | 2024 | 42 | 0.900 |
Why?
|
Parkinson Disease | 9 | 2022 | 2877 | 0.900 |
Why?
|
Head-Down Tilt | 1 | 2023 | 65 | 0.890 |
Why?
|
Carbon Dioxide | 2 | 2024 | 1147 | 0.790 |
Why?
|
Syncope, Vasovagal | 1 | 2021 | 38 | 0.750 |
Why?
|
Primary Dysautonomias | 1 | 2021 | 28 | 0.750 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2021 | 62 | 0.740 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2021 | 106 | 0.720 |
Why?
|
Disaccharides | 1 | 2021 | 170 | 0.710 |
Why?
|
Valsalva Maneuver | 3 | 2021 | 99 | 0.650 |
Why?
|
Sweat Glands | 1 | 2019 | 33 | 0.640 |
Why?
|
Hypocapnia | 1 | 2018 | 38 | 0.640 |
Why?
|
Hypotension, Orthostatic | 1 | 2021 | 258 | 0.610 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 94 | 0.560 |
Why?
|
Skin Physiological Phenomena | 1 | 2017 | 188 | 0.550 |
Why?
|
Insulin | 7 | 2023 | 6597 | 0.540 |
Why?
|
Sweating | 1 | 2017 | 155 | 0.540 |
Why?
|
Deep Brain Stimulation | 5 | 2011 | 832 | 0.530 |
Why?
|
Tryptases | 3 | 2021 | 176 | 0.520 |
Why?
|
Galvanic Skin Response | 1 | 2017 | 358 | 0.500 |
Why?
|
Heparin | 1 | 2021 | 1634 | 0.440 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1886 | 0.420 |
Why?
|
Autoantibodies | 1 | 2021 | 2116 | 0.400 |
Why?
|
Mast Cells | 4 | 2024 | 1392 | 0.400 |
Why?
|
Administration, Intranasal | 6 | 2022 | 477 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 12148 | 0.320 |
Why?
|
Electrophysiology | 1 | 2011 | 1262 | 0.310 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 664 | 0.300 |
Why?
|
Dermis | 1 | 2008 | 202 | 0.280 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 2 | 2019 | 41 | 0.280 |
Why?
|
Action Potentials | 2 | 2011 | 1834 | 0.280 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1601 | 0.250 |
Why?
|
Reflex | 2 | 2021 | 376 | 0.250 |
Why?
|
Blood Flow Velocity | 6 | 2024 | 1371 | 0.250 |
Why?
|
Middle Cerebral Artery | 3 | 2024 | 275 | 0.240 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2024 | 281 | 0.230 |
Why?
|
Middle Aged | 41 | 2024 | 220920 | 0.230 |
Why?
|
Retrospective Studies | 12 | 2024 | 80646 | 0.230 |
Why?
|
Humans | 59 | 2024 | 761572 | 0.230 |
Why?
|
Hypoglycemic Agents | 5 | 2022 | 3085 | 0.210 |
Why?
|
Pilot Projects | 3 | 2023 | 8633 | 0.190 |
Why?
|
Dizziness | 1 | 2024 | 259 | 0.190 |
Why?
|
Biopsy | 3 | 2022 | 6766 | 0.190 |
Why?
|
Monitoring, Intraoperative | 2 | 2009 | 942 | 0.190 |
Why?
|
Aged | 29 | 2024 | 169310 | 0.170 |
Why?
|
Female | 40 | 2024 | 392686 | 0.170 |
Why?
|
Male | 40 | 2024 | 360842 | 0.170 |
Why?
|
Cerebral Infarction | 3 | 2010 | 983 | 0.160 |
Why?
|
Adult | 20 | 2024 | 221203 | 0.150 |
Why?
|
Syncope | 1 | 2021 | 427 | 0.150 |
Why?
|
Hand Strength | 1 | 2021 | 456 | 0.150 |
Why?
|
Microelectrodes | 2 | 2011 | 306 | 0.150 |
Why?
|
Duodenum | 1 | 2021 | 490 | 0.150 |
Why?
|
Double-Blind Method | 7 | 2023 | 12341 | 0.150 |
Why?
|
Neural Conduction | 2 | 2019 | 441 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 840 | 0.140 |
Why?
|
Vasoconstriction | 2 | 2011 | 592 | 0.140 |
Why?
|
Vasodilation | 2 | 2013 | 962 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 612 | 0.140 |
Why?
|
Posture | 3 | 2010 | 957 | 0.130 |
Why?
|
Functional Laterality | 3 | 2011 | 2257 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2015 | 2421 | 0.120 |
Why?
|
Brain | 8 | 2022 | 27120 | 0.120 |
Why?
|
Serine | 1 | 2019 | 830 | 0.120 |
Why?
|
Postural Balance | 2 | 2010 | 622 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1552 | 0.120 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2016 | 247 | 0.120 |
Why?
|
Electroencephalography | 2 | 2007 | 6237 | 0.110 |
Why?
|
Anaphylaxis | 1 | 2021 | 757 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1200 | 0.100 |
Why?
|
Memory | 2 | 2020 | 2193 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2016 | 1574 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 751 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1860 | 0.090 |
Why?
|
Stereotaxic Techniques | 2 | 2009 | 555 | 0.090 |
Why?
|
Atrophy | 2 | 2011 | 1633 | 0.080 |
Why?
|
Huntington Disease | 1 | 2016 | 1144 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2018 | 22176 | 0.080 |
Why?
|
Stroke | 5 | 2015 | 9758 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 10 | 2014 | 36429 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1705 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2011 | 518 | 0.080 |
Why?
|
Disability Evaluation | 2 | 2012 | 1836 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 198 | 0.070 |
Why?
|
Neurons | 1 | 2007 | 9463 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2576 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2735 | 0.070 |
Why?
|
Electromyography | 1 | 2011 | 1394 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 405 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26127 | 0.070 |
Why?
|
Genetic Variation | 1 | 2021 | 6567 | 0.060 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 485 | 0.060 |
Why?
|
Brain Mapping | 2 | 2011 | 6635 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2400 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1496 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20099 | 0.060 |
Why?
|
Brain Infarction | 2 | 2003 | 290 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2022 | 58986 | 0.060 |
Why?
|
Preoperative Care | 2 | 2009 | 2242 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 628 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 54426 | 0.050 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2003 | 56 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10212 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2005 | 453 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 64684 | 0.050 |
Why?
|
Tachycardia | 1 | 2005 | 600 | 0.050 |
Why?
|
Cognition | 3 | 2020 | 6992 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3766 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 310 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4484 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15843 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 313 | 0.040 |
Why?
|
Hypertension | 3 | 2008 | 8540 | 0.040 |
Why?
|
Disease Progression | 2 | 2015 | 13510 | 0.040 |
Why?
|
Florida | 1 | 2021 | 431 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3826 | 0.040 |
Why?
|
Anti-Allergic Agents | 1 | 2021 | 153 | 0.040 |
Why?
|
Urticaria | 1 | 2021 | 150 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11670 | 0.040 |
Why?
|
Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2019 | 42 | 0.040 |
Why?
|
Research Design | 2 | 2020 | 6180 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1078 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3267 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2005 | 834 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 174 | 0.040 |
Why?
|
Hemodynamics | 1 | 2007 | 4160 | 0.040 |
Why?
|
Eating | 1 | 2023 | 1539 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 750 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 455 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4415 | 0.030 |
Why?
|
Image Enhancement | 2 | 2005 | 2885 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2846 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1432 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.030 |
Why?
|
Brain Ischemia | 2 | 2009 | 3049 | 0.030 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2015 | 100 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 150 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39107 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2426 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168467 | 0.030 |
Why?
|
Parkinsonian Disorders | 1 | 2015 | 284 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8002 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14607 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12954 | 0.020 |
Why?
|
Acceleration | 1 | 2011 | 189 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3032 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2009 | 15633 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2011 | 492 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3551 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9326 | 0.020 |
Why?
|
Neuronavigation | 1 | 2009 | 166 | 0.020 |
Why?
|
Atlases as Topic | 1 | 2009 | 248 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 945 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9319 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 244 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6391 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59255 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 476 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 132 | 0.020 |
Why?
|
Levodopa | 1 | 2007 | 221 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2007 | 184 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12947 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 88324 | 0.020 |
Why?
|
Cerebellar Diseases | 1 | 2007 | 220 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3322 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2008 | 930 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 791 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2009 | 840 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 841 | 0.010 |
Why?
|
Gait | 1 | 2009 | 814 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 1987 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16592 | 0.010 |
Why?
|
Hyperventilation | 1 | 2003 | 78 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41493 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2003 | 9031 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1389 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7054 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1911 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2094 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 542 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17904 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2850 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2002 | 554 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2009 | 2639 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3416 | 0.010 |
Why?
|
Respiration | 1 | 2005 | 1657 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42230 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2001 | 633 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1272 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2001 | 941 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7827 | 0.010 |
Why?
|
Calcinosis | 1 | 2001 | 1469 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9002 | 0.010 |
Why?
|
Child | 1 | 2021 | 80156 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20571 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5311 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30054 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2002 | 2656 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8466 | 0.010 |
Why?
|
Ultrasonography | 1 | 2001 | 5972 | 0.000 |
Why?
|
United States | 1 | 2015 | 72335 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 39970 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74213 | 0.000 |
Why?
|